SITC21 – What to Watch out for
It’s time to kick off our yearly coverage of the Society for Immunotherapy of Cancer (SITC) annual meeting being held in DC next month.
It’s a hybrid meeting with quite a bit of variety compared to previous years we have written about, at least based on the abstract title reviews conducted so far.
This year’s meeting has moved from National Harbor across to the convention center in Washington DC, making for a change of scene and pace – will the data live up to the billing?
In our initial Preview, we take a look at some of the emerging IO trends that stood out…
BSB subscribers can read up on our ongoing commentary and analysis from the cancer conference season for our meeting coverage at SITC – you can either log-in or click to access our latest analysis.
This content is restricted to subscribers
